ESBL-E faecal carriage risk factors | Patients | (%age) |
---|---|---|
ESBL-E previous colonization within 12 months | 16/55 | 29% |
Travel in a ESBL-E endemic area within 12 months | 2/55 | 3,6% |
Previous hospitalization within 12 months | 37/55 | 67% |
Health-care associated | 26/55 | 47% |
Previous antimicrobial therapy within 12 months | 35/47 | 74% |
Penicillin | 26/41 | 63% |
3rd generation cephalosporins | 17/41 | 41% |
Fluroquinolones | 9/41 | 22% |
Trimethoprim/sulfamethoxazole | 7/41 | 17% |
Aminoglycosids | 9/41 | 22% |
0 risk factor | 10/47 | 21% |
1 risk factor | 5/47 | 11% |
2 risk factors | 9/47 | 19% |
3 risk factors | 12/47 | 26% |
4 risk factors | 11/47 | 23% |
5 risk factors | 0/47 0% |